References
- Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982;101:782–5.
- Bøhles H, Richter K, Wagner-Thiessen E, Schäfer H. Decreased serum carnitine in valproate induced Reye syndrome. Eur J Pediatr 1982;139:185–6.
- Malaguarnera M, Pistone G, Elvira R, Leotto C, Scarpella Linda. Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 2005;11:7197–202.
- Heureux PER, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol 2009;47:101–11.
- Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta JA, Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 2007;11:R10.
- Bøhmer T. Drug-induced carnitine deficiency. In: Seim H, Løster H, editors. Carnitine: pathobiochemical basics and clinical applications. Bochum, Germany: Ponte Press; 1996. pp. 167–76.
- Bøhmer T, Rydning A, Solberg HE. Carnitine levels in human serum in health and disease. Clin Chim Acta 1974;57:55–61.